Estrogen receptor alpha mediated repression of PRICKLE1 destabilizes REST and promotes uterine fibroid pathogenesis.

Autor: McWilliams MM; Department of Cell Biology and Physiology, Center for Reproductive Sciences, Institute for Reproduction and Developmental Sciences, University of Kansas Medical Center, Kansas City, KS., Koohestani F; Department of Cell Biology and Physiology, Center for Reproductive Sciences, Institute for Reproduction and Developmental Sciences, University of Kansas Medical Center, Kansas City, KS., Jefferson WN; Reproductive and Developmental Biology Laboratory, National Institute of Environmental Health Sciences, Research Triangle Park, NC., Gunewardena S; Department of Cell Biology and Physiology, Center for Reproductive Sciences, Institute for Reproduction and Developmental Sciences, University of Kansas Medical Center, Kansas City, KS., Shivashankar K; Department of Cell Biology and Physiology, Center for Reproductive Sciences, Institute for Reproduction and Developmental Sciences, University of Kansas Medical Center, Kansas City, KS., Wertenberger RA; Department of Cell Biology and Physiology, Center for Reproductive Sciences, Institute for Reproduction and Developmental Sciences, University of Kansas Medical Center, Kansas City, KS., Williams CJ; Reproductive and Developmental Biology Laboratory, National Institute of Environmental Health Sciences, Research Triangle Park, NC., Kumar TR; Division of Reproductive Sciences, Department of Obstetrics & Gynecology, University of Colorado Denver-Anschutz Medical Campus, Aurora, CO 80045., Chennathukuzhi VM; Department of Cell Biology and Physiology, Center for Reproductive Sciences, Institute for Reproduction and Developmental Sciences, University of Kansas Medical Center, Kansas City, KS.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Sep 09. Date of Electronic Publication: 2024 Sep 09.

Characterization of m ⁶ A modifiers and RNA modifications in uterine fibroids.

Autor: George JW; Olson Center for Women's Health, Department of Obstetrics and Gynecology, University of Nebraska Medical Center, Omaha, NE 68198, USA.; Veterans Affairs Nebraska Western Iowa Health Care System, 4101 Woolworth Ave, Omaha, NE 68105, USA., Cancino RA; Olson Center for Women's Health, Department of Obstetrics and Gynecology, University of Nebraska Medical Center, Omaha, NE 68198, USA., Miller JLG; Olson Center for Women's Health, Department of Obstetrics and Gynecology, University of Nebraska Medical Center, Omaha, NE 68198, USA., Qiu F; Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE, USA., Lin Q; RNA Epitranscriptomics and Proteomics Resource, Department of Chemistry, University at Albany, Albany, NY, United States., Rowley MJ; Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, Nebraska., Chennathukuzhi VM; Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USA., Davis JS; Olson Center for Women's Health, Department of Obstetrics and Gynecology, University of Nebraska Medical Center, Omaha, NE 68198, USA.; Veterans Affairs Nebraska Western Iowa Health Care System, 4101 Woolworth Ave, Omaha, NE 68105, USA.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2023 Aug 09. Date of Electronic Publication: 2023 Aug 09.

Loss of REST in breast cancer promotes tumor progression through estrogen sensitization, MMP24 and CEMIP overexpression.

Autor: Cloud AS; Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, USA., Vargheese AM; Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, USA.; The University of Kansas Cancer Center, Kansas City, KS, USA.; University of Kansas, Lawrence, KS, USA., Gunewardena S; Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, USA.; Department of Biostatistics, University of Kansas Medical Center, Kansas City, KS, USA., Shimak RM; The University of Kansas Cancer Center, Kansas City, KS, USA.; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Ganeshkumar S; Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, USA., Kumaraswamy E; The University of Kansas Cancer Center, Kansas City, KS, USA.; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Jensen RA; The University of Kansas Cancer Center, Kansas City, KS, USA.; University of Kansas, Lawrence, KS, USA.; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA.; Department of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, KS, USA., Chennathukuzhi VM; Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, USA. vchennathukuzhi@kumc.edu.; The University of Kansas Cancer Center, Kansas City, KS, USA. vchennathukuzhi@kumc.edu.

Publikováno v: BMC cancer [BMC Cancer] 2022 Feb 17; Vol. 22 (1), pp. 180. Date of Electronic Publication: 2022 Feb 17.

Safety and efficacy of sirolimus in recurrent intravenous leiomyomatosis, pulmonary benign metastatic leiomyomatosis, and leiomyomatosis peritonealis disseminata: a pilot study.

Autor: Guorui Zhang¹ (AUTHOR), Rong Fan¹ (AUTHOR), Hua Yang¹ (AUTHOR), Hao Su¹ (AUTHOR), Xin Yu¹ (AUTHOR), Yutong Wang¹ (AUTHOR), Fengzhi Feng¹ (AUTHOR) fengfz1969@sina.com, Lan Zhu¹ (AUTHOR) zhu_julie@vip.sina.com

Publikováno v: BMC Medicine. 3/13/2024, Vol. 22 Issue 1, p1-8. 8p. 3 Charts, 4 Graphs.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.